Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Bacterial biofilm-derived H-NS protein acts as a defense against Neutrophil Extracellular Traps (NETs).

NPJ biofilms and microbiomes·2025
Same author

Bacterial biofilm-derived H-NS protein acts as a defense against Neutrophil Extracellular Traps (NETs).

NPJ biofilms and microbiomes·2025
Same author

Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?

Antioxidants (Basel, Switzerland)·2023
Same author

Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.

ESMO open·2021
Same author

The homogenous alternative to biomineralization: Zn- and Mn-rich materials enable sharp organismal "tools" that reduce force requirements.

Scientific reports·2021
Same author

Hydrogen isotopic analysis of nuclear reactor materials using ultrafast laser-induced breakdown spectroscopy.

Optics express·2021

Related Experiment Video

Updated: Jun 3, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity.

A Shoemark1, A Devaraj, M Meister

  • 1Host Defence Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.

Respiratory Medicine
|March 15, 2011
PubMed
Summary

Peripheral airway nitric oxide (C(alv)) is elevated in bronchiectasis, reflecting disease severity. However, this measurement does not aid in acute treatment decisions for patients with this lung condition.

More Related Videos

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology

Background:

  • Bronchiectasis involves neutrophilic airway inflammation and susceptibility to bacterial infections.
  • Current methods for monitoring lung inflammation in bronchiectasis are often invasive, indirect, or lack sensitivity.
  • Exhaled nitric oxide (FE(NO)) is a non-invasive marker used in other airway diseases.

Purpose of the Study:

  • To investigate if peripheral airway nitric oxide (C(alv)) can serve as a direct, clinically useful measure of lung inflammation in bronchiectasis patients.
  • To compare C(alv) levels in stable bronchiectasis patients, those with exacerbations, and healthy controls.

Main Methods:

  • Studied 53 stable bronchiectasis patients, 20 during exacerbation, and 30 healthy controls.
  • Measured exhaled nitric oxide (FE(NO)) using chemiluminescence.
  • Employed two pulmonary exchange dynamics models to differentiate proximal and peripheral contributions to FE(NO).

Main Results:

  • FE(NO) was significantly higher in bronchiectasis patients versus controls (p < 0.05).
  • Compartmental modeling indicated elevated peripheral airway NO (C(alv)) in bronchiectasis (3.6 ppb) compared to controls (2.7 ppb), while proximal NO levels were normal.
  • C(alv) correlated with disease severity (lung function, HRCT) and quality of life scores, but FE(NO) parameters did not change during exacerbations or after treatment.

Conclusions:

  • Elevated peripheral airway nitric oxide (C(alv)) in bronchiectasis reflects disease severity.
  • C(alv) shows potential as a non-invasive marker for assessing chronic inflammation and disease burden in bronchiectasis.
  • Current FE(NO) measurements do not provide actionable insights for acute treatment decisions in bronchiectasis exacerbations.